Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Small Cell Lung Carcinoma 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 34Carboplatin 32pembrolizumab 28Pemetrexed 27Magnetic Resonance Spectroscopy 27Cisplatin 22Paclitaxel 15Gemcitabine 13durvalumab 12Docetaxel 12osimertinib 11Nivolumab 11atezolizumab 8Immunoglobulin G 8Disulfides 8Taxes 7Etoposide 7130-nm albumin-bound paclitaxel 7Radiotherapy 6Radiosurgery 6Radiation 6Platinum 6Cetuximab 6Biopsy 6X-Rays 51,2-diaminocyclohexaneplatinum II citrate 5Ramucirumab 4Observation 4Irinotecan 4Albumin-Bound Paclitaxel 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × Dihematoporphyrin Ether × 30 days × Clear all
NCT03735095 2026-05-14

Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer

Roswell Park Cancer Institute

Phase 1/2 Completed
19 enrolled 10 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡